Apidra injection cart, containing insulin glulisine (recombinant), is a rapid-acting insulin produced by Sanofi to improve glycemic control in patients with diabetes mellitus. This injectable drug, with YJ code 2492418A2020, is provided as 300 units per tube.
Apidra injection cart
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).